Drug Type Small molecule drug |
Synonyms SKL 15508, SKL 20540, SKL A4R + [3] |
Target |
Mechanism α7 receptor agonists(Neuronal acetylcholine receptor protein alpha-7 subunit agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Schizophrenia | Phase 2 | US | 01 Jul 2014 | |
Cognition Disorders | Phase 2 | US | - | |
Cognition Disorders | Phase 2 | - | - | |
Behavioural disorders | Phase 1 | KR | 28 Nov 2018 |